Your browser doesn't support javascript.
loading
Tumor markers as an entry for SARS-CoV-2 infection?
Xia, Pu; Dubrovska, Anna.
Affiliation
  • Xia P; OncoRay - National Center for Radiation Research in Oncology, Faculty of Medicine, University Hospital Carl Gustav Carus, Technische Universität Dresden, Helmholtz-Zentrum Dresden-Rossendorf, Dresden, Germany.
  • Dubrovska A; OncoRay - National Center for Radiation Research in Oncology, Faculty of Medicine, University Hospital Carl Gustav Carus, Technische Universität Dresden, Helmholtz-Zentrum Dresden-Rossendorf, Dresden, Germany.
FEBS J ; 287(17): 3677-3680, 2020 09.
Article in En | MEDLINE | ID: mdl-32738184
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Biomarkers, Tumor / Basigin / Spike Glycoprotein, Coronavirus / Antineoplastic Agents, Immunological / COVID-19 Drug Treatment / Neoplasms Type of study: Prognostic_studies Limits: Humans Language: En Journal: FEBS J Journal subject: BIOQUIMICA Year: 2020 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Biomarkers, Tumor / Basigin / Spike Glycoprotein, Coronavirus / Antineoplastic Agents, Immunological / COVID-19 Drug Treatment / Neoplasms Type of study: Prognostic_studies Limits: Humans Language: En Journal: FEBS J Journal subject: BIOQUIMICA Year: 2020 Document type: Article Affiliation country: Country of publication: